Image generated by DALL-E, AI image generator In last week’s post, “The role and impact of IP rights on innovation and investment in RM,” I discussed the importance of intellectual property (IP) rights in regenerative medicine (RM), highlighting how they drive innovation and secure competitive advantages. The discussion covered various aspects, such as the role...

Continue reading

Intellectual property (IP) rights in regenerative medicine (RM) are crucial for sparking innovation and staying ahead in a competitive market. Protecting inventions through patents and other IP rights encourages investment by giving inventors exclusive market rights. This also ensures that new advancements are eventually disseminated widely. Patents grant an exclusive monopoly for a set period...

Continue reading

Portrait of cancer patient. Image source: vecteezy.com Cancer remains the second leading cause of death worldwide. The Canadian Cancer Society estimates about 247,100 new cancer cases and 88,100 cancer deaths in Canada in 2024. Ten million deaths worldwide have been estimated to have been caused by cancer in 2020. This number is expected to be over...

Continue reading

As June comes to an end, so does Pride Month in Canada. In 12 years of blogging for Signals, I realize I have never covered the topic of STEM (science, technology, engineering and mathematics) and Pride, although I have written about Equity, Diversity and Inclusion (EDI) and featured EngiQueers, founded at McMaster University. In the...

Continue reading

“Regenerative medicine news under the microscope” is a monthly feature highlighting a selection of impactful research findings and headlines across the many subfields of regenerative medicine. Throughout the past month, I’ve spotted some notable trends emerging in the rapidly evolving field of cell therapy. In this special edition of “Regenerative Medicine News Under the Microscope,”...

Continue reading

Image source: Canva Have you wondered how many cell and gene therapies (CGTs) have been approved in Canada? So did I. To track the number down, I first turned to my trusty internet search engine with hopes that a list of Health Canada-approved CGTs would already exist online. Notably, it was exciting to see that...

Continue reading

Laya Kiani has a degree in Pharmaceutical Chemistry from the University of Guelph, which she combines with a keen passion for business and marketing. She has shifted her focus toward the business side of health care, driven by a desire to make significant impacts in the health science sector. Dedicated to continuous learning and professional...

Continue reading

Motor neuron progenitors (green) derived from human embryonic stem cells. Such neurons could be used to treat spinal cord injuries and diseases of the motor neurons. This photo was taken by Sharyn Rossi in the lab of Hans Keirstead at the University of California, Irvine. Learn more about CIRM-funded stem cell research: www.cirm.ca.gov Spinal cord...

Continue reading

“Regenerative medicine news under the microscope” is a monthly feature highlighting a selection of impactful research findings and headlines across the many subfields of regenerative medicine. I’ve gone slightly longer form with this month’s edition, as I found that our coverage of April’s biggest stories would benefit from some additional contextual information. I cover a...

Continue reading

CCRM, the publisher of Signals, has enhanced its long-standing relationship with the University of Toronto’s Medicine by Design through a new strategic alliance. This profile is one in a series of profiles that feature “people” of Medicine by Design. Some minor edits may have been made to the original published version. Omar F. Khan, Assistant...

Continue reading